CEPI and Codiak BioSciences Partner to Develop Broadly Protective Betacoronavirus Vaccine

The Coalition for Epidemic Preparedness Innovations (CEPI) and Codiak BioSciences announced the latest funding award under CEPI’s US $200m program to advance the development of vaccines that provide broad protection against SARS-CoV-2 and other Betacoronaviruses.